Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.81m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Treasury shares issued & Director Holdings

31 Jul 2015 07:00

RNS Number : 6488U
Science Group PLC
31 July 2015
Β 

Β 

31 July 2015

Science Group plc

("Science Group" or the "Company")

Treasury shares issued & Director Holdings

Science Group plc (AIM:SAG) announces that on 30 July 2015 the Company issued 2,574,000 treasury shares at an average price of 40.54 pence per share in settlement of the exercise of share options. At the time of settlement, the Company will receive cash of Β£1.0 million from this exercise.

Of this amount, 2,500,000 treasury shares were issued at a price of 40.0 pence per share in settlement of the exercise of share options by Martyn Ratcliffe, Chairman of Science Group. These share options were specifically approved by independent shareholders in relation to Mr Ratcliffe's 2010 investment. Mr Ratcliffe has held these options for over five years and has exercised them now in order to provide liquidity in the Company's shares to satisfy demand from independent institutional shareholders. The exercise used the cashless exercise mechanism approved by shareholders at the AGM in 2013, with 1,600,000 shares sold in the market to fund the option price and partially satisfy tax obligations arising from this option exercise. The remaining 900,000 shares have been retained by Mr Ratcliffe. As a result, Mr Ratcliffe's shareholding as a percentage of the total issued share capital remains similar to that prior to this option exercise and the net cash effect is that Mr Ratcliffe has made a further investment of approximately Β£100,000 in the Company.

The Takeover Panel has previously waived the obligations under Rule 9 of the City Code in respect of Mr Ratcliffe in connection with the exercise of these share options, subject to shareholder approval, which was given by shareholders at the 2012 AGM on 16 April 2012. The Takeover Panel has confirmed that it requires nothing further in respect of this option exercise and Mr Ratcliffe is not required to make an offer under Rule 9 of the Code.

Mr Ratcliffe retains no other share options in the Company.

Following this announcement, the following directors of Science Group plc have interests in the ordinary shares of the Company as follows:

Β 

No. of shares held

% holding of ISC (exc treasury)

Β Martyn Ratcliffe

13,412,906

32.88%

David Courtley

375,000

0.92%

Β 

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 40,793,948. Science Group plc holds 1,268,087 shares in treasury.

Β 

-Ends-

Β 

For further information:

Science Group plc

Β 

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Hemsted, Finance Director

www.sciencegroup.com

Β 

Numis Securities Limited

Β 

Nominated Adviser: Oliver Cardigan / Simon Willis

Corporate Broking: James Serjeant

Tel: +44 (0) 20 7260 1000

Β 

Media enquiries:

Abchurch

Β 

Jamie Hooper

Tel: +44 (0) 20 7398 7719

jamie.hooper@abchurch-group.com

www.abchurch-group.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEAEXEDFPSEAF
Date   Source Headline
29th Jun 20267:00 amRNSTransaction in Own Shares
26th Jun 20267:00 amRNSTransaction in Own Shares
24th Jun 20267:00 amRNSTransaction in Own Shares
23rd Jun 20267:00 amRNSTransaction in Own Shares
18th Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 20267:00 amRNSTransaction in Own Shares
16th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:01 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTreasury shares issued
1st Jun 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:01 amRNSTransaction in Own Shares
27th May 20267:00 amRNSIssue of share options and PDMR dealing
22nd May 20267:00 amRNSTreasury Shares Issued
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20261:05 pmRNSResult of Annual General Meeting
20th May 20267:01 amRNSAGM Trading Update and Capital Allocation
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:01 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTreasury Shares Issued
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:01 amRNSNotice of Annual General Meeting
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTreasury Shares Issued
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.